WallStSmart
CELC

Celcuity LLC

NASDAQ: CELC · HEALTHCARE · BIOTECHNOLOGY

$121.35
+1.97% today

Updated 2026-04-30

Market cap
$5.80B
P/E ratio
P/S ratio
EPS (TTM)
$-3.79
Dividend yield
52W range
$10 – $129
Volume
0.7M

Celcuity LLC (CELC) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+6.1%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+2.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.6%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+8.6%
2025-11-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$-0.73+30.5%$112.51$106.04-5.8%
2025-11-12$-0.78+11.4%$79.17$86.00+8.6%
2025-08-14$-1.04-18.2%$52.37$51.79-1.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.05$-0.73+30.5%
2025-09-30$-0.88$-0.78+11.4%$154000.00
2025-06-30$-0.88$-1.04-18.2%
2025-03-31$-0.86$-0.85+0.6%
2024-12-31$-0.67$-0.75-11.9%$121344.00-47.2%
2024-09-30$-0.70$-0.65+7.1%
2024-06-30$-0.68$-0.62+8.8%
2024-03-31$-0.71$-0.64+9.9%
2023-12-31$-0.73$-0.65+11.0%$229648.00
2023-09-30$-0.68$-0.83-22.1%
2023-06-30$-0.60$-0.66-10.0%

Frequently asked questions

Has Celcuity LLC beaten earnings estimates?
Celcuity LLC has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +6.1% over the last 4 quarters.
How does CELC stock react to earnings?
CELC stock has moved an average of +0.6% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.